ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI

Sep 9, 2026
UpDoc will lead work on an autonomous clinical AI system for cardiovascular care through a federal award of up to $9.2 million.

UpDoc said in a press release that ARPA-H selected it as a lead performer in the ADVOCATE program, with an award of up to $9.2 million. Microsoft, OpenAI and NVIDIA are supporting the UpDoc led team. ADVOCATE has more than one lead performer: Atman Health announced a separate award under the same program on the same day.

The program will run for 39 months in multiple phases. It will develop and test an autonomous clinical AI system for cardiovascular disease and heart failure, covering medication, diet and exercise management under physician oversight and clinical safeguards.

Planned work includes independent testing, comparisons with cardiologists, FDA Investigational Device Exemption trials and deployment at large health systems with electronic health record integration. The new system has not received FDA clearance, and participation in later program phases depends on competitive milestone reviews.

We hope you enjoyed this article

Free newsletter

AI Policy Brief

Weekly report on AI regulations, safety standards, government policies, and compliance requirements worldwide.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.